SJM MRI Diagnostic Imaging Registry (IDE)
Launched by ABBOTT MEDICAL DEVICES · Jun 17, 2016
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
This study will be performed as part of a regulated, prospective, non-randomized, multi-center clinical study.
Subjects will be enrolled, undergo a clinically-indicated MRI scan, and have an assessment of adverse events, device measurements, and clinical utility of the MRI scan images.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient is implanted with a market-released St. Jude Medical pacemaker, ICD, or CRT current generation device listed in the study protocol and any market-released pacing or defibrillation lead.
- • 2. Patient's device and all leads must be implanted for at least 6 weeks prior to the scheduled date of the MRI.
- • 3. Patient has a clinical indication for a non-thoracic MRI scan, where MRI is the imaging modality of choice that will give adequate results to manage the patient.
- • 4. Patient is scheduled for a non-thoracic MRI scan up to 1.5T.
- • 5. Patient has a pacemaker, ICD, or CRT device implanted pectorally.
- • 6. Patient has the ability to provide informed consent for study participation and be willing and able to comply with the study procedures.
- • 7. Patient is 18 years or above, or of legal age to give informed consent specific to state and national law.
- Exclusion Criteria:
- • 1. Patient has an ICD/CRT-D and is pacemaker dependent
- • 2. Capture threshold is greater than 2.5 volts at 0.5 ms for RA and RV leads
- • 3. Pacing lead impedance is NOT within range (i.e. ≥ 200 and ≤ 2000 ohms)
- • 4. High voltage lead impedance (HVLI) is NOT within range (i.e. ≥ 20 and ≤ 200 ohms)
- • 5. Patient has a device generator battery voltage at elective replacement interval (ERI)
- • 6. Patient has another existing active implanted medical device (e.g. neurostimulator, infusion pump, etc.) that has MR labeling that will not allow the MRI scans to be completed.
- • 7. Patient has other non-MRI compatible device or material implanted
- NOTE:
- • MRI compatible knee replacements, hip replacements, stents, etc. may be included as long as the labeling of these devices allow MRI scans conducted per this protocol
- • MRI compatible mechanical, prosthetic, and bioprosthetic heart valves may be included as long as the labeling of these devices allow for MRI scans conducted per this protocol
- • Non-removable dental implants may be included
- • 8. Patient has a lead extender, adaptor, or capped/abandoned lead
- • 9. Patient is pregnant
About Abbott Medical Devices
Abbott Medical Devices is a leading global healthcare company dedicated to advancing medical technology through innovative research and development. With a robust portfolio of diagnostic, therapeutic, and monitoring solutions, Abbott is committed to improving patient outcomes and enhancing the quality of care across various medical fields. The company places a strong emphasis on clinical trials to validate the safety and efficacy of its products, ensuring compliance with regulatory standards and fostering collaboration with healthcare professionals. By leveraging cutting-edge science and technology, Abbott Medical Devices aims to address pressing health challenges and deliver transformative solutions that empower patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Bethesda, Maryland, United States
Rancho Mirage, California, United States
Portland, Oregon, United States
Norfolk, Virginia, United States
Pittsburgh, Pennsylvania, United States
Hartford, Connecticut, United States
Park Ridge, Illinois, United States
Kansas City, Kansas, United States
Shreveport, Louisiana, United States
Cleveland, Ohio, United States
Orlando, Florida, United States
Takoma Park, Maryland, United States
Lynchburg, Virginia, United States
Newark, Delaware, United States
Kansas City, Missouri, United States
Bellevue, Washington, United States
Jupiter, Florida, United States
Chattanooga, Tennessee, United States
Roslyn, New York, United States
Tyler, Texas, United States
Langhorne, Pennsylvania, United States
Littleton, Colorado, United States
Eugene, Oregon, United States
Loveland, Colorado, United States
San Francisco, California, United States
Scottsdale, Arizona, United States
Tucson, Arizona, United States
Fresno, California, United States
Concord, California, United States
Indianapolis, Indiana, United States
Fort Worth, Texas, United States
Springfield, Illinois, United States
Winston Salem, North Carolina, United States
Milwaukee, Wisconsin, United States
Newport Beach, California, United States
Sayre, Pennsylvania, United States
Saint Louis, Missouri, United States
Burbank, California, United States
Boca Raton, Florida, United States
Athens, Georgia, United States
Auburn Hills, Michigan, United States
Corvallis, Oregon, United States
Charleston, South Carolina, United States
Seattle, Washington, United States
Jonesboro, Arkansas, United States
Bakersfield, California, United States
Deer Park, California, United States
North Hollywood, California, United States
Santa Barbara, California, United States
Ashland, Kentucky, United States
Jackson, Mississippi, United States
Columbia, Missouri, United States
Kearney, Nebraska, United States
Denville, New Jersey, United States
Rochester, New York, United States
Allentown, Pennsylvania, United States
Danville, Pennsylvania, United States
Patients applied
Trial Officials
Grant Kim
Study Director
Abbott Medical Devices
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials